Announcements Trials

Browse Landscape

Phase

Phase 1 11 Phase 2 5 Phase 2/3 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 121 Breast Neoplasms 81 Neoplasms 75 Colorectal Neoplasms 65 Neoplasm Metastasis 64 Leukemia, Myeloid, Acute 62 Prostatic Neoplasms 59 Recurrence 53 Pancreatic Neoplasms 51 Ovarian Neoplasms 50 Multiple Myeloma 50 Triple Negative Breast Neoplasms 36 Lung Neoplasms 36 Melanoma 35 Squamous Cell Carcinoma of Head and Neck 33 Lymphoma, Non-Hodgkin 33 Glioblastoma 31 Carcinoma, Renal Cell 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma 28 Endometrial Neoplasms 28 Carcinoma, Hepatocellular 28 Stomach Neoplasms 26 Small Cell Lung Carcinoma 26 Leukemia, Lymphocytic, Chronic, B-Cell 26 Myelodysplastic Syndromes 24 Lymphoma, Follicular 24 Lymphoma, B-Cell 24 Sarcoma 23

Interventions

Sonication 1 Drug Therapy 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gliosarcoma × 90 days × Clear all

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡